Organization and Expression of the Kaposi’s Sarcoma-Associated Herpesvirus Genome



Primary Effusion Lymphoma Lytic Replication Lytic Gene Tetradecanoyl Phorbol Acetate Terminal Repeat Sequence 


  1. 1.
    Abe, Y., D. Matsubara, H. Gatanaga, S. Oka, S. Kimura, Y. Sasao, K. Saitoh, T. Fujii, Y. Sato, T. Sata, and H. Katano. 2006. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease. Pathol Int 56:617–24.PubMedCrossRefGoogle Scholar
  2. 2.
    Alazard, N., H. Gruffat, E. Hiriart, A. Sergeant, and E. Manet. 2003. Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin. J Virol 77:8166–72.PubMedCrossRefGoogle Scholar
  3. 3.
    Albrecht, J. C., J. Nicholas, K. R. Cameron, C. Newman, B. Fleckenstein, and R. W. Honess. 1992. Herpesvirus saimiri has a gene specifying a homologue of the cellular membrane glycoprotein CD59. Virology 190:527–30.PubMedCrossRefGoogle Scholar
  4. 4.
    Alexander, L., L. Denekamp, A. Knapp, M. R. Auerbach, B. Damania, and R. C. Desrosiers. 2000. The primary sequence of rhesus monkey rhadinovirus isolate 26–95: sequence similarities to Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus isolate 17577. J Virol 74:3388–98.PubMedCrossRefGoogle Scholar
  5. 5.
    An, F. Q., N. Compitello, E. Horwitz, M. Sramkoski, E. S. Knudsen, and R. Renne. 2005. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest. J Biol Chem 280:3862–74.PubMedCrossRefGoogle Scholar
  6. 6.
    Arvanitakis, L., E. Geras-Raaka, A. Varma, M. C. Gershengorn, and E. Cesarman. 1997. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385:347–50.PubMedCrossRefGoogle Scholar
  7. 7.
    AuCoin, D. P., K. S. Colletti, Y. Xu, S. A. Cei, and G. S. Pari. 2002. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains two functional lytic origins of DNA replication. J Virol 76:7890–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Ballestas, M. E., P. A. Chatis, and K. M. Kaye. 1999. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284:641–4.PubMedCrossRefGoogle Scholar
  9. 9.
    Ballestas, M. E., and K. M. Kaye. 2001. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. J Virol 75:3250–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Barbera, A. J., J. V. Chodaparambil, B. Kelley-Clarke, V. Joukov, J. C. Walter, K. Luger, and K. M. Kaye. 2006. The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 311:856–61.PubMedCrossRefGoogle Scholar
  11. 11.
    Bechtel, J. T., Y. Liang, J. Hvidding, and D. Ganem. 2003. Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol 77:6474–81.PubMedCrossRefGoogle Scholar
  12. 12.
    Bieleski, L., and S. J. Talbot. 2001. Kaposi's sarcoma-associated herpesvirus vCyclin open reading frame contains an internal ribosome entry site. J Virol 75:1864–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Birkmann, A., K. Mahr, A. Ensser, S. Yaguboglu, F. Titgemeyer, B. Fleckenstein, and F. Neipel. 2001. Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1. J Virol 75:11583–93.PubMedCrossRefGoogle Scholar
  14. 14.
    Bornkamm, G. W., H. Delius, B. Fleckenstein, F. J. Werner, and C. Mulder. 1976. Structure of Herpesvirus saimiri genomes: arrangement of heavy and light sequences in the M genome. J Virol 19:154–61.PubMedGoogle Scholar
  15. 15.
    Boshoff, C., Y. Endo, P. D. Collins, Y. Takeuchi, J. D. Reeves, V. L. Schweickart, M. A. Siani, T. Sasaki, T. J. Williams, P. W. Gray, P. S. Moore, Y. Chang, and R. A. Weiss. 1997. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278:290–4.PubMedCrossRefGoogle Scholar
  16. 16.
    Brinkmann, M. M., M. Pietrek, O. Dittrich-Breiholz, M. Kracht, and T. F. Schulz. 2007. Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus. J Virol 81:42–58.PubMedCrossRefGoogle Scholar
  17. 17.
    Burysek, L., and P. M. Pitha. 2001. Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. J Virol 75:2345–52.PubMedCrossRefGoogle Scholar
  18. 18.
    Cadwell, K., and L. Coscoy. 2005. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 309:127–30.PubMedCrossRefGoogle Scholar
  19. 19.
    Cai, X., and B. R. Cullen. 2006. Transcriptional origin of Kaposi's sarcoma-associated herpesvirus microRNAs. J Virol 80:2234–42.PubMedCrossRefGoogle Scholar
  20. 20.
    Cai, X., S. Lu, Z. Zhang, C. M. Gonzalez, B. Damania, and B. R. Cullen. 2005. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci U S A 102:5570–5.PubMedCrossRefGoogle Scholar
  21. 21.
    Cannon, M. 2007. The KSHV and other human herpesviral G protein-coupled receptors. Curr Top Microbiol Immunol 312:137–56.PubMedCrossRefGoogle Scholar
  22. 22.
    Cesarman, E., Y. Chang, P. S. Moore, J. W. Said, and D. M. Knowles. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186–91.PubMedCrossRefGoogle Scholar
  23. 23.
    Cesarman, E., P. S. Moore, P. H. Rao, G. Inghirami, D. M. Knowles, and Y. Chang. 1995. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86:2708–14.PubMedGoogle Scholar
  24. 24.
    Chang, Y., E. Cesarman, M. S. Pessin, F. Lee, J. Culpepper, D. M. Knowles, and P. S. Moore. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma [see comments]. Science 266:1865–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Chatterjee, M., J. Osborne, G. Bestetti, Y. Chang, and P. S. Moore. 2002. Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298:1432–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Chen, L., and M. Lagunoff. 2005. Establishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells. J Virol 79:14383–91.PubMedCrossRefGoogle Scholar
  27. 27.
    Cheng, E. H., J. Nicholas, D. S. Bellows, G. S. Hayward, H. G. Guo, M. S. Reitz, and J. M. Hardwick. 1997. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci U S A 94:690–4.PubMedCrossRefGoogle Scholar
  28. 28.
    Choi, J. K., B. S. Lee, S. N. Shim, M. Li, and J. U. Jung. 2000. Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome [In Process Citation]. J Virol 74:436–46.PubMedCrossRefGoogle Scholar
  29. 29.
    Chung, Y. H., R. E. Means, J. K. Choi, B. S. Lee, and J. U. Jung. 2002. Kaposi's sarcoma-associated herpesvirus OX2 glycoprotein activates myeloid-lineage cells to induce inflammatory cytokine production. J Virol 76:4688–98.PubMedCrossRefGoogle Scholar
  30. 30.
    Conrad, N. K., S. Mili, E. L. Marshall, M. D. Shu, and J. A. Steitz. 2006. Identification of a rapid mammalian deadenylation-dependent decay pathway and its inhibition by a viral RNA element. Mol Cell 24:943–53.PubMedCrossRefGoogle Scholar
  31. 31.
    Conrad, N. K., and J. A. Steitz. 2005. A Kaposi's sarcoma virus RNA element that increases the nuclear abundance of intronless transcripts. Embo J 24:1831–41.PubMedCrossRefGoogle Scholar
  32. 32.
    Coscoy, L. 2007. Immune evasion by Kaposi's sarcoma-associated herpesvirus. Nat Rev Immunol 7:391–401.PubMedCrossRefGoogle Scholar
  33. 33.
    Coscoy, L., and D. Ganem. 2000. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci U S A 97:8051–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Cotter, M. A., 2nd, and E. S. Robertson. 1999. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells [In Process Citation]. Virology 264:254–64.PubMedCrossRefGoogle Scholar
  35. 35.
    Deng, H., A. Young, and R. Sun. 2000. Auto-activation of the rta gene of human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus. J Gen Virol 81:3043–8.PubMedGoogle Scholar
  36. 36.
    Dittmer, D., M. Lagunoff, R. Renne, K. Staskus, A. Haase, and D. Ganem. 1998. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol 72:8309–15.PubMedGoogle Scholar
  37. 37.
    Dittmer, D. P. 2003. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. Cancer Res 63:2010–5.PubMedGoogle Scholar
  38. 38.
    Dourmishev, L. A., A. L. Dourmishev, D. Palmeri, R. A. Schwartz, and D. M. Lukac. 2003. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev 67:175–212, (Table of contents).PubMedCrossRefGoogle Scholar
  39. 39.
    Dupin, N., C. Fisher, P. Kellam, S. Ariad, M. Tulliez, N. Franck, E. van Marck, D. Salmon, I. Gorin, J.P. Escande, R. A. Weiss, K. Alitalo, and C. Boshoff. 1999. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A 96:4546–51.PubMedCrossRefGoogle Scholar
  40. 40.
    Fakhari, F. D., and D. P. Dittmer. 2002. Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR. J Virol 76:6213–23.PubMedCrossRefGoogle Scholar
  41. 41.
    Friborg, J., Jr., W. Kong, M. O. Hottiger, and G. J. Nabel. 1999. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402:889–94.PubMedGoogle Scholar
  42. 42.
    Fujimuro, M., and S. D. Hayward. 2003. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta. J Virol 77:8019–30.PubMedCrossRefGoogle Scholar
  43. 43.
    Fujimuro, M., F. Y. Wu, C. ApRhys, H. Kajumbula, D. B. Young, G. S. Hayward, and S. D. Hayward. 2003. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat Med 9:300–6.PubMedCrossRefGoogle Scholar
  44. 44.
    Ganem, D. 1997. KSHV and Kaposi's sarcoma: the end of the beginning? Cell 91:157–60.PubMedCrossRefGoogle Scholar
  45. 45.
    Garber, A. C., J. Hu, and R. Renne. 2002. Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication. J Biol Chem 277:27401–11.PubMedCrossRefGoogle Scholar
  46. 46.
    Grundhoff, A., and D. Ganem. 2001. Mechanisms governing expression of the v-FLIP gene of Kaposi's sarcoma-associated herpesvirus. J Virol 75:1857–63.PubMedCrossRefGoogle Scholar
  47. 47.
    Grundhoff, A., C. S. Sullivan, and D. Ganem. 2006. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. Rna 12:733–50.PubMedCrossRefGoogle Scholar
  48. 48.
    Guasparri, I., S. A. Keller, and E. Cesarman. 2004. KSHV vFLIP is essential for the survival of infected lymphoma cells. J Exp Med 199:993–1003.PubMedCrossRefGoogle Scholar
  49. 49.
    Hammerschmidt, W., and B. Sugden. 1988. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55:427–33.PubMedCrossRefGoogle Scholar
  50. 50.
    Hayward, G. S., and J. C. Zong. 2007. Modern evolutionary history of the human KSHV genome. Curr Top Microbiol Immunol 312:1–42.PubMedCrossRefGoogle Scholar
  51. 51.
    Hu, J., A. C. Garber, and R.Renne. 2002. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J Virol 76:11677–87.PubMedCrossRefGoogle Scholar
  52. 52.
    Hu, J., and R. Renne. 2005. Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin. J Virol 79:2637–42.PubMedCrossRefGoogle Scholar
  53. 53.
    Ishido, S., C. Wang, B. S. Lee, G. B. Cohen, and J. U. Jung. 2000. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74:5300–9.PubMedCrossRefGoogle Scholar
  54. 54.
    Izumiya, Y., S. F. Lin, T. J. Ellison, A. M. Levy, G. L. Mayeur, C. Izumiya, and H. J. Kung. 2003. Cell cycle regulation by Kaposi's sarcoma-associated herpesvirus K-bZIP: direct interaction with cyclin-CDK2 and induction of G1 growth arrest. J Virol 77:9652–61.PubMedCrossRefGoogle Scholar
  55. 55.
    Jenner, R.G., M.M. Alba, C. Boshoff, and P. Kellam. 2001. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol 75:891–902.PubMedCrossRefGoogle Scholar
  56. 56.
    Katano, H., T. Sata, T. Suda, T. Nakamura, N. Tachikawa, H. Nishizumi, S. Sakurada, Y. Hayashi, M. Koike, A. Iwamoto, T. Kurata, and S.Mori. 1999. Expression and antigenicity of human herpesvirus 8 encoded ORF59 protein in AIDS-associated Kaposi's sarcoma. J Med Virol 59:346–55.PubMedCrossRefGoogle Scholar
  57. 57.
    Katano, H., Y. Sato, H. Itoh, and T. Sata. 2001. Expression of human herpesvirus 8 (HHV-8)-encoded immediate early protein, open reading frame 50, in HHV-8-associated diseases. J Hum Virol 4:96–102.PubMedGoogle Scholar
  58. 58.
    Katano, H., Y. Sato, T. Kurata, S. Mori, and T. Sata. 2000. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Virology 269:335–44.PubMedCrossRefGoogle Scholar
  59. 59.
    Katano, H., Y. Sato, T. Kurata, S. Mori, and T. Sata. 1999. High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma. Am J Pathol 155:47–52.PubMedCrossRefGoogle Scholar
  60. 60.
    Kedes, D. H., M. Lagunoff, R. Renne, and D. Ganem. 1997. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J Clin Invest 100:2606–10.PubMedCrossRefGoogle Scholar
  61. 61.
    Kliche, S., W. Nagel, E. Kremmer, C. Atzler, A. Ege, T. Knorr, U. Koszinowski, W. Kolanus, and J. Haas. 2001. Signaling by human herpesvirus 8 kaposin A through direct membrane recruitment of cytohesin-1. Mol Cell 7:833–43.PubMedCrossRefGoogle Scholar
  62. 62.
    Krishnan, H. H., P. P. Naranatt, M. S. Smith, L. Zeng, C. Bloomer, and B. Chandran. 2004. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J Virol 78:3601–20.PubMedCrossRefGoogle Scholar
  63. 63.
    Lagunoff, M., R. Majeti, A. Weiss, and D. Ganem. 1999. Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 96:5704–9.PubMedCrossRefGoogle Scholar
  64. 64.
    Lee, H., R. Veazey, K. Williams, M. Li, J. Guo, F. Neipel, B. Fleckenstein, A. Lackner, R. C. Desrosiers, and J. U. Jung. 1998. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat Med 4:435–40.PubMedCrossRefGoogle Scholar
  65. 65.
    Leight, E. R., and B. Sugden. 2000. EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Rev Med Virol 10:83–100.PubMedCrossRefGoogle Scholar
  66. 66.
    Li, H., T. Komatsu, B. J. Dezube, and K. M. Kaye. 2002. The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter. J Virol 76:11880–8.PubMedCrossRefGoogle Scholar
  67. 67.
    Li, M., H. Lee, J. Guo, F. Neipel, B. Fleckenstein, K. Ozato, and J.U. Jung. 1998. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J Virol 72:5433–40.PubMedGoogle Scholar
  68. 68.
    Li, M., H. Lee, D. W. Yoon, J. C. Albrecht, B. Fleckenstein, F. Neipel, and J. U. Jung. 1997. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J Virol 71:1984–91.PubMedGoogle Scholar
  69. 69.
    Lim, C., H. Sohn, D. Lee, Y. Gwack, and J. Choe. 2002. Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. J Virol 76:10320–31.PubMedCrossRefGoogle Scholar
  70. 70.
    Lin, C. L., H. Li, Y. Wang, F. X. Zhu, S. Kudchodkar, and Y. Yuan. 2003. Kaposi's sarcoma-associated herpesvirus lytic origin (ori-Lyt)-dependent DNA replication: identification of the ori-Lyt and association of K8 bZip protein with the origin. J Virol 77:5578–88.PubMedCrossRefGoogle Scholar
  71. 71.
    Lin, S. F., D. R. Robinson, G. Miller, and H. J. Kung. 1999. Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus. J Virol 73:1909–17.PubMedGoogle Scholar
  72. 72.
    Lomonte, P., M. Bublot, V. van Santen, G. M. Keil, P. P. Pastoret, and E. Thiry. 1995. Analysis of bovine herpesvirus 4 genomic regions located outside the conserved gammaherpesvirus gene blocks. J Gen Virol 76 ( Pt 7):1835–41.PubMedCrossRefGoogle Scholar
  73. 73.
    Low, W., M. Harries, H. Ye, M. Q. Du, C. Boshoff, and M. Collins. 2001. Internal ribosome entry site regulates translation of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein. J Virol 75:2938–45.PubMedCrossRefGoogle Scholar
  74. 74.
    Lukac, D. M., R. Renne, J. R. Kirshner, and D. Ganem. 1998. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252:304–12.PubMedCrossRefGoogle Scholar
  75. 75.
    Marshall, V., T. Parks, R. Bagni, C. D. Wang, M. A. Samols, J. Hu, K. M. Wyvil, K. Aleman, R. F. Little, R. Yarchoan, R. Renne, and D. Whitby. 2007. Conservation of virally encoded micrornas in Kaposi sarcoma--associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric castleman disease. J Infect Dis 195:645–59.PubMedCrossRefGoogle Scholar
  76. 76.
    Matsumura, S., Y. Fujita, E. Gomez, N. Tanese, and A. C. Wilson. 2005. Activation of Kaposi's sarcoma-associated Herpesvirus major latency locus by the lytic switch protein RTA (ORF50). J Virol 79, 8493–505.PubMedCrossRefGoogle Scholar
  77. 77.
    Matta, H., and P. M. Chaudhary. 2004. Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP). Proc Natl Acad Sci U S A 101:9399–404.PubMedCrossRefGoogle Scholar
  78. 78.
    McCormick, C., and D. Ganem. 2005. The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 307:739–41.PubMedCrossRefGoogle Scholar
  79. 79.
    Miller, G., L. Heston, E. Grogan, L. Gradoville, M. Rigsby, R. Sun, D. Shedd, V. M. Kushnaryov, S. Grossberg, and Y. Chang. 1997. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J Virol 71:314–24.PubMedGoogle Scholar
  80. 80.
    Muralidhar, S., A. M. Pumfery, M. Hassani, M. R. Sadaie, M. Kishishita, J. N. Brady, J. Doniger, P. Medveczky, and L. J. Rosenthal. 1998. Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene [published erratum appears in J Virol 1999 Mar; 73(3):2568]. J Virol 72:4980–8.PubMedGoogle Scholar
  81. 81.
    Nakamura, H., M. Lu, Y. Gwack, J. Souvlis, S. L. Zeichner, and J. U. Jung. 2003. Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J Virol 77:4205–20.PubMedCrossRefGoogle Scholar
  82. 82.
    Neipel, F., J. C. Albrecht, and B. Fleckenstein. 1997. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? J Virol 71:4187–92.PubMedGoogle Scholar
  83. 83.
    Nicholas, J., V. R. Ruvolo, W. H. Burns, G. Sandford, X. Wan, D. Ciufo, S. B. Hendrickson, H. G. Guo, G. S. Hayward, and M. S. Reitz. 1997. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med 3:287–92.PubMedCrossRefGoogle Scholar
  84. 84.
    O'Connor, C. M., and D. H. Kedes. 2007. Rhesus monkey rhadinovirus: a model for the study of KSHV. Curr Top Microbiol Immunol 312:43–69.PubMedCrossRefGoogle Scholar
  85. 85.
    Pari, G. S., D. AuCoin, K. Colletti, S. A. Cei, V. Kirchoff, and S. W. Wong. 2001. Identification of the rhesus macaque rhadinovirus lytic origin of DNA replication. J Virol 75:11401–7.PubMedCrossRefGoogle Scholar
  86. 86.
    Parravicini, C., B. Chandran, M. Corbellino, E. Berti, M. Paulli, P. S. Moore, and Y. Chang. 2000. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol 156:743–9.PubMedCrossRefGoogle Scholar
  87. 87.
    Paulose-Murphy, M., N. K. Ha, C. Xiang, Y. Chen, L. Gillim, R. Yarchoan, P. Meltzer, M. Bittner, J. Trent, and S. Zeichner. 2001. Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus). J Virol 75:4843–53.PubMedCrossRefGoogle Scholar
  88. 88.
    Pearce, M., S. Matsumura, and A. C. Wilson. 2005. Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter. J Virol 79:14457–64.PubMedCrossRefGoogle Scholar
  89. 89.
    Pfeffer, S., A. Sewer, M. Lagos-Quintana, R. Sheridan, C. Sander, F. A. Grasser, L. F. van Dyk, C. K. Ho, S. Shuman, M. Chien, J. J. Russo, J. Ju, G. Randall, B. D. Lindenbach, C. M. Rice, V. Simon, D. D. Ho, M. Zavolan, and T. Tuschl. 2005. Identification of microRNAs of the herpesvirus family. Nat Methods 2:269–276.PubMedCrossRefGoogle Scholar
  90. 90.
    Pfeffer, S., M. Zavolan, F. A. Grasser, M. Chien, J. J. Russo, J. Ju, B. John, A. J. Enright, D. Marks, C. Sander, and T. Tuschl. 2004. Identification of virus-encoded microRNAs. Science 304:734–6.PubMedCrossRefGoogle Scholar
  91. 91.
    Pitha, P. M., W. C. Au, W. Lowther, Y. T. Juang, S. L. Schafer, L. Burysek, J. Hiscott, and P. A. Moore. 1998. Role of the interferon regulatory factors (IRFs) in virus-mediated signaling and regulation of cell growth. Biochimie 80:651–8.PubMedCrossRefGoogle Scholar
  92. 92.
    Radkov, S. A., P. Kellam, and C. Boshoff. 2000. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 6:1121–7.PubMedCrossRefGoogle Scholar
  93. 93.
    Rainbow, L., G. M. Platt, G. R. Simpson, R. Sarid, S. J. Gao, H. Stoiber, C. S. Herrington, P. S. Moore, and T. F. Schulz. 1997. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 71:5915–21.PubMedGoogle Scholar
  94. 94.
    Reed, J. A., R. G. Nador, D. Spaulding, Y. Tani, E. Cesarman, and D. M. Knowles. 1998. Demonstration of Kaposi's sarcoma-associated herpes virus cyclin D homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system. Blood 91:3825–32.PubMedGoogle Scholar
  95. 95.
    Renne, R., C. Barry, D. Dittmer, N. Compitello, P. O. Brown, and D. Ganem. 2001. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol 75:458–68.PubMedCrossRefGoogle Scholar
  96. 96.
    Renne, R., D. Blackbourn, D. Whitby, J. Levy, and D. Ganem. 1998. Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol 72:5182–8.PubMedGoogle Scholar
  97. 97.
    Renne, R., M. Lagunoff, W. Zhong, and D. Ganem. 1996. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol 70:8151–4.PubMedGoogle Scholar
  98. 98.
    Renne, R., W. Zhong, B. Herndier, M. McGrath, N. Abbey, D. Kedes, and D. Ganem. 1996. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 2:342–6.PubMedCrossRefGoogle Scholar
  99. 99.
    Roizman, B., and A. E. Sears. 1993. Herpes Simplex viruses and their replication, p. 11–68. In B. Roizman, R. J. Whitley, and C. Lopez (ed.), The Human Herpesviruses. Raven Press, New York, NY.Google Scholar
  100. 100.
    Rose, T. M., K. B. Strand, E. R. Schultz, G. Schaefer, G. W. Rankin, Jr., M. E. Thouless, C. C. Tsai, and M. L. Bosch. 1997. Identification of two homologs of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in retroperitoneal fibromatosis of different macaque species. J Virol 71:4138–44.PubMedGoogle Scholar
  101. 101.
    Russo, J. J., R. A. Bohenzky, M. C. Chien, J. Chen, M. Yan, D. Maddalena, J. P. Parry, D. Peruzzi, I. S. Edelman, Y. Chang, and P. S. Moore. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 93:14862–7.PubMedCrossRefGoogle Scholar
  102. 102.
    Sadler, R., L. Wu, B. Forghani, R. Renne, W. Zhong, B. Herndier, and D. Ganem. 1999. A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J Virol 73:5722–30.PubMedGoogle Scholar
  103. 103.
    Samols, M. A., J. Hu, R. L. Skalsky, and R. Renne. 2005. Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J Virol 79:9301–5.PubMedCrossRefGoogle Scholar
  104. 104.
    Samols, M. A., Hu, J., Skalsky, R.L., Maldonado, A.M., Riva, A., Lopez, M.C., Baker, H.V., and R. Renne. 2007. Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog 3(5):e65.Google Scholar
  105. 105.
    Sarid, R., O. Flore, R. A. Bohenzky, Y. Chang, and P. S. Moore. 1998. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol 72:1005–12.PubMedGoogle Scholar
  106. 106.
    Sarid, R., T. Sato, R. A. Bohenzky, J. J. Russo, and Y. Chang. 1997. Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med 3:293–8.PubMedCrossRefGoogle Scholar
  107. 107.
    Saveliev, A., F. Zhu, and Y. Yuan. 2002. Transcription mapping and expression patterns of genes in the major immediate-early region of Kaposi's sarcoma-associated herpesvirus. Virology 299:301–14.PubMedCrossRefGoogle Scholar
  108. 108.
    Schultz, E. R., G. W. Rankin, Jr., M. P. Blanc, B. W. Raden, C. C. Tsai, and T. M. Rose. 2000. Characterization of two divergent lineages of macaque rhadinoviruses related to Kaposi's sarcoma-associated herpesvirus. J Virol 74:4919–28.PubMedCrossRefGoogle Scholar
  109. 109.
    Seaman, W. T., D. Ye, R. X. Wang, E. E. Hale, M. Weisse, and E. B. Quinlivan. 1999. Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus. Virology 263:436–49.PubMedCrossRefGoogle Scholar
  110. 110.
    Searles, R. P., E. P. Bergquam, M. K. Axthelm, and S. W. Wong. 1999. Sequence and genomic analysis of a Rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J Virol 73:3040–53.PubMedGoogle Scholar
  111. 111.
    Sharp, T. V., H. W. Wang, A. Koumi, D. Hollyman, Y. Endo, H. Ye, M. Q. Du, and C. Boshoff. 2002. K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J Virol 76:802–16.PubMedCrossRefGoogle Scholar
  112. 112.
    Soulier, J., L. Grollet, E. Oksenhendler, P. Cacoub, D. Cazals-Hatem, P. Babinet, M. F. d'Agay, J. P. Clauvel, M. Raphael, L. Degos, et al. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276–80.PubMedGoogle Scholar
  113. 113.
    Staskus, K. A., R. Sun, G. Miller, P. Racz, A. Jaslowski, C. Metroka, H. Brett-Smith, and A. T. Haase. 1999. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol 73:4181–7.PubMedGoogle Scholar
  114. 114.
    Stedman, W., Z. Deng, F. Lu, and P. M. Lieberman. 2004. ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin. J Virol 78:12566–75.PubMedCrossRefGoogle Scholar
  115. 115.
    Sun, R., S. F. Lin, L. Gradoville, and G. Miller. 1996. Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 93:11883–8.PubMedCrossRefGoogle Scholar
  116. 116.
    Sun, R., S. F. Lin, L. Gradoville, Y. Yuan, F. Zhu, and G. Miller. 1998. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 95:10866–71.PubMedCrossRefGoogle Scholar
  117. 117.
    Sun, R., S. F. Lin, K. Staskus, L. Gradoville, E. Grogan, A. Haase, and G. Miller. 1999. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J Virol 73:2232–42.PubMedGoogle Scholar
  118. 118.
    Talbot, S. J., R. A. Weiss, P. Kellam, and C. Boshoff. 1999. Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. Virology 257:84–94.PubMedCrossRefGoogle Scholar
  119. 119.
    Tang, S., K. Yamanegi, and Z. M. Zheng. 2004. Requirement of a 12-base-pair TATT-containing sequence and viral lytic DNA replication in activation of the Kaposi's sarcoma-associated herpesvirus K8.1 late promoter. J Virol 78:2609–14.PubMedCrossRefGoogle Scholar
  120. 120.
    Taylor, J. L., H. N. Bennett, B. A. Snyder, P. S. Moore, and Y. Chang. 2005. Transcriptional analysis of latent and inducible Kaposi's sarcoma-associated herpesvirus transcripts in the K4 to K7 region. J Virol 79:15099–106.PubMedCrossRefGoogle Scholar
  121. 121.
    Tomescu, C., W. K. Law, and D. H. Kedes. 2003. Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus. J Virol 77:9669–84.PubMedCrossRefGoogle Scholar
  122. 122.
    Tomlinson, C. C., and B. Damania. 2004. The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway. J Virol 78:1918–27.PubMedCrossRefGoogle Scholar
  123. 123.
    Verma, S. C., T. Choudhuri, R. Kaul, and E. S. Robertson. 2006. Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats. J Virol 80:2243–56.PubMedCrossRefGoogle Scholar
  124. 124.
    Verma, S. C., T. Choudhuri, and E. S. Robertson. 2007. The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner. J Virol 81:3402–13.PubMedCrossRefGoogle Scholar
  125. 125.
    Wang, F. Z., S. M. Akula, N. P. Pramod, L. Zeng, and B. Chandran. 2001. Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate. J Virol 75:7517–27.PubMedCrossRefGoogle Scholar
  126. 126.
    Wang, H. W., T. V. Sharp, A. Koumi, G. Koentges, and C. Boshoff. 2002. Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin. Embo J 21:2602–15.PubMedCrossRefGoogle Scholar
  127. 127.
    Wang, H. W., M. W. Trotter, D. Lagos, D. Bourboulia, S. Henderson, T. Makinen, S. Elliman, A. M. Flanagan, K. Alitalo, and C. Boshoff. 2004. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36:687–93.PubMedCrossRefGoogle Scholar
  128. 128.
    Wang, X. H., R. Aliyari, W. X. Li, H. W. Li, K. Kim, R. Carthew, P. Atkinson, and S. W. Ding. 2006. RNA interference directs innate immunity against viruses in adult Drosophila. Science 312:452–4.PubMedCrossRefGoogle Scholar
  129. 129.
    Wang, Y., H. Li, M. Y. Chan, F. X. Zhu, D. M. Lukac, and Y. Yuan. 2004. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription. J Virol 78:8615–29.PubMedCrossRefGoogle Scholar
  130. 130.
    Wang, Y., Q. Tang, G. G. Maul, and Y. Yuan. 2006. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: dual role of replication and transcription activator. J Virol 80:12171–86.PubMedCrossRefGoogle Scholar
  131. 131.
    Wu, F. Y., Q. Q. Tang, H. Chen, C. ApRhys, C. Farrell, J. Chen, M. Fujimuro, M. D. Lane, and G. S. Hayward. 2002. Lytic replication-associated protein (RAP) encoded by Kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through CCAAT/enhancer-binding protein-alpha. Proc Natl Acad Sci U S A 99:10683–8.PubMedCrossRefGoogle Scholar
  132. 132.
    Wu, F. Y., S. E. Wang, Q. Q. Tang, M. Fujimuro, C. J. Chiou, Q. Zheng, H. Chen, S. D. Hayward, M. D. Lane, and G. S. Hayward. 2003. Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1). J Virol 77:8893–914.PubMedCrossRefGoogle Scholar
  133. 133.
    Xu, Y., A. Rodriguez-Huete, and G. S. Pari. 2006. Evaluation of the Lytic Origins of Replication of Kaposi's Sarcoma-Associated Virus/Human Herpesvirus 8 in the Context of the Viral Genome. J Virol 80:9905–9.PubMedCrossRefGoogle Scholar
  134. 134.
    Yamanegi, K., S. Tang, and Z. M. Zheng. 2005. Kaposi's sarcoma-associated herpesvirus K8beta is derived from a spliced intermediate of K8 pre-mRNA and antagonizes K8alpha (K-bZIP) to induce p21 and p53 and blocks K8alpha-CDK2 interaction. J Virol 79:14207–21.PubMedCrossRefGoogle Scholar
  135. 135.
    Zheng, Z. M. 2003. Split genes and their expression in Kaposi's sarcoma-associated herpesvirus. Rev Med Virol 13:173–84.PubMedCrossRefGoogle Scholar
  136. 136.
    Zhong, W., H. Wang, B. Herndier, and D. Ganem. 1996. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci U S A 93:6641–6.PubMedCrossRefGoogle Scholar
  137. 137.
    Zhu, F. X., T. Cusano, and Y. Yuan. 1999. Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus. J Virol 73:5556–67.PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2009

Authors and Affiliations

  1. 1.Department of Microbiology, School of Dental MedicineUniversity of PennsylvaniaPhiladelphiaUSA
  2. 2.Department of Molecular Genetics and MicrobiologyUniversity of FloridaGainesvilleUSA

Personalised recommendations